{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:13:36Z","timestamp":1784297616444,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Research and Development Program of Hubei Province","award":["2021BCA114"],"award-info":[{"award-number":["2021BCA114"]}]},{"name":"Research Fund of the Health Commission of Hubei Province","award":["WJ2021M255"],"award-info":[{"award-number":["WJ2021M255"]}]},{"name":"Cancer research and translational platform project of Zhongnan Hospital of Wuhan University","award":["ZLYNXM202004"],"award-info":[{"award-number":["ZLYNXM202004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00259-023-06137-z","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T15:38:17Z","timestamp":1676993897000},"page":"2152-2166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical prospective study of Gallium 68 (68Ga)\u2013labeled fibroblast-activation protein inhibitor PET\/CT in the diagnosis of biliary tract carcinoma"],"prefix":"10.1007","volume":"50","author":[{"given":"Li","family":"Jinghua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Kui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Deliang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liao","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Haitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Yaqun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Dongde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xigang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Shengli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhiyong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Yueming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Zhonglin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yufeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"6137_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma Nat Rev Dis Primers. 2021;7:65. https:\/\/doi.org\/10.1038\/s41572-021-00300-2.","journal-title":"Cholangiocarcinoma Nat Rev Dis Primers"},{"key":"6137_CR2","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cncr.29692","volume":"122","author":"NF Esnaola","year":"2016","unstructured":"Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122:1349\u201369. https:\/\/doi.org\/10.1002\/cncr.29692.","journal-title":"Cancer"},{"key":"6137_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"6137_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/liv.14086","volume":"39","author":"A Forner","year":"2019","unstructured":"Forner A, Vidili G, Rengo M, Bujanda L, Ponz-Sarvise M, Lamarca A. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver Int. 2019;39(Suppl 1):98\u2013107. https:\/\/doi.org\/10.1111\/liv.14086.","journal-title":"Liver Int"},{"key":"6137_CR5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.2214\/AJR.19.22239","volume":"214","author":"GR Schooler","year":"2020","unstructured":"Schooler GR, Hull NC, Lee EY. Hepatobiliary MRI contrast agents: pattern recognition approach to pediatric focal hepatic lesions. AJR Am J Roentgenol. 2020;214:976\u201386. https:\/\/doi.org\/10.2214\/AJR.19.22239.","journal-title":"AJR Am J Roentgenol"},{"key":"6137_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1148\/radiol.14132362","volume":"273","author":"JY Choi","year":"2014","unstructured":"Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology. 2014;273:30\u201350. https:\/\/doi.org\/10.1148\/radiol.14132362.","journal-title":"Radiology."},{"key":"6137_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2007.07.002","volume":"206","author":"CU Corvera","year":"2008","unstructured":"Corvera CU, Blumgart LH, Akhurst T, DeMatteo RP, D\u2019Angelica M, Fong Y, et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg. 2008;206:57\u201365. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2007.07.002.","journal-title":"J Am Coll Surg"},{"key":"6137_CR8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00259-002-0852-z","volume":"29","author":"T Kato","year":"2002","unstructured":"Kato T, Tsukamoto E, Kuge Y, Katoh C, Nambu T, Nobuta A, et al. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging. 2002;29:1047\u201354. https:\/\/doi.org\/10.1007\/s00259-002-0852-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6137_CR9","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12149-017-1164-5","volume":"31","author":"A Singnurkar","year":"2017","unstructured":"Singnurkar A, Poon R, Metser U. Comparison of 18F-FDG-PET\/CT and 18F-FDG-PET\/MR imaging in oncology: a systematic review. Ann Nucl Med. 2017;31:366\u201378. https:\/\/doi.org\/10.1007\/s12149-017-1164-5.","journal-title":"Ann Nucl Med"},{"key":"6137_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2967\/jnumed.121.262609","volume":"63","author":"JR Salas","year":"2022","unstructured":"Salas JR, Clark PM. Signaling pathways that drive (18)F-FDG accumulation in cancer. J Nucl Med. 2022;63:659\u201363. https:\/\/doi.org\/10.2967\/jnumed.121.262609.","journal-title":"J Nucl Med"},{"key":"6137_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1148\/rg.2016150102","volume":"36","author":"P Ziai","year":"2016","unstructured":"Ziai P, Hayeri MR, Salei A, Salavati A, Houshmand S, Alavi A, et al. Role of optimal quantification of FDG PET imaging in the clinical practice of radiology. Radiographics. 2016;36:481\u201396. https:\/\/doi.org\/10.1148\/rg.2016150102.","journal-title":"Radiographics"},{"key":"6137_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12877-018-0846-8","volume":"18","author":"X Li","year":"2018","unstructured":"Li X, Zhang Y, Zhang Y. (18)F-FDG PET\/CT may be a suitable method for preoperative diagnosis and evaluation of Chinese older patients with hilar cholangiocarcinoma. BMC Geriatr. 2018;18:150. https:\/\/doi.org\/10.1186\/s12877-018-0846-8.","journal-title":"BMC Geriatr"},{"key":"6137_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174\u201386. https:\/\/doi.org\/10.1038\/s41568-019-0238-1.","journal-title":"Nat Rev Cancer"},{"key":"6137_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson DA. Diversity and biology of cancer-associated fibroblasts. Physiol Rev. 2021;101:147\u201376. https:\/\/doi.org\/10.1152\/physrev.00048.2019.","journal-title":"Physiol Rev"},{"key":"6137_CR15","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","volume":"76","author":"X Yang","year":"2016","unstructured":"Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, et al. FAP Promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res. 2016;76:4124\u201335. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2973.","journal-title":"Cancer Res"},{"key":"6137_CR16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39:783\u2013803. https:\/\/doi.org\/10.1007\/s10555-020-09909-3.","journal-title":"Cancer Metastasis Rev"},{"key":"6137_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2967\/jnumed.120.245084","volume":"62","author":"FL Giesel","year":"2021","unstructured":"Giesel FL, Adeberg S, Syed M, Lindner T, Jimenez-Franco LD, Mavriopoulou E, et al. FAPI-74 PET\/CT using either (18)F-AlF or cold-kit (68)Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung cancer patients. J Nucl Med. 2021;62:201\u20137. https:\/\/doi.org\/10.2967\/jnumed.120.245084.","journal-title":"J Nucl Med"},{"key":"6137_CR18","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2967\/jnumed.119.237016","volume":"61","author":"SA Koerber","year":"2020","unstructured":"Koerber SA, Staudinger F, Kratochwil C, Adeberg S, Haefner MF, Ungerechts G, et al. The role of (68)Ga-FAPI PET\/CT for patients with malignancies of the lower gastrointestinal tract: first clinical experience. J Nucl Med. 2020;61:1331\u20136. https:\/\/doi.org\/10.2967\/jnumed.119.237016.","journal-title":"J Nucl Med"},{"key":"6137_CR19","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, et al. Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47:1820\u201332. https:\/\/doi.org\/10.1007\/s00259-020-04769-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6137_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1148\/radiol.2020203275","volume":"298","author":"Y Pang","year":"2021","unstructured":"Pang Y, Zhao L, Luo Z, Hao B, Wu H, Lin Q, et al. Comparison of (68)Ga-FAPI and (18)F-FDG uptake in gastric, duodenal, and colorectal cancers. Radiology. 2021;298:393\u2013402. https:\/\/doi.org\/10.1148\/radiol.2020203275.","journal-title":"Radiology"},{"key":"6137_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2967\/jnumed.120.256271","volume":"62","author":"RJ Hicks","year":"2021","unstructured":"Hicks RJ, Roselt PJ, Kallur KG, Tothill RW, Mileshkin L. FAPI PET\/CT: Will It End the Hegemony of (18)F-FDG in Oncology? J Nucl Med. 2021;62:296\u2013302. https:\/\/doi.org\/10.2967\/jnumed.120.256271.","journal-title":"J Nucl Med"},{"key":"6137_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1148\/radiol.213118","volume":"304","author":"L Lan","year":"2022","unstructured":"Lan L, Zhang S, Xu T, Liu H, Wang W, Feng Y, et al. Prospective comparison of (68)Ga-FAPI versus (18)F-FDG PET\/CT for tumor staging in biliary tract cancers. Radiology. 2022;304:648\u201357. https:\/\/doi.org\/10.1148\/radiol.213118.","journal-title":"Radiology"},{"key":"6137_CR23","doi-asserted-by":"publisher","unstructured":"Dendl K, Koerber SA, Kratochwil C, Cardinale J, Finck R, Dabir M, et al. 2021 FAP and FAPI-PET\/CT in malignant and non-malignant diseases: a perfect symbiosis? Cancers (Basel). 13 https:\/\/doi.org\/10.3390\/cancers13194946.","DOI":"10.3390\/cancers13194946"},{"key":"6137_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2967\/jnumed.120.244806","volume":"62","author":"A Altmann","year":"2021","unstructured":"Altmann A, Haberkorn U, Siveke J. The latest developments in imaging of fibroblast activation protein. J Nucl Med. 2021;62:160\u20137. https:\/\/doi.org\/10.2967\/jnumed.120.244806.","journal-title":"J Nucl Med"},{"key":"6137_CR25","doi-asserted-by":"publisher","first-page":"693640","DOI":"10.3389\/fonc.2021.693640","volume":"11","author":"H Wang","year":"2021","unstructured":"Wang H, Zhu W, Ren S, Kong Y, Huang Q, Zhao J, et al. (68)Ga-FAPI-04 versus (18)F-FDG PET\/CT in the detection of hepatocellular carcinoma. Front Oncol. 2021;11:693640. https:\/\/doi.org\/10.3389\/fonc.2021.693640.","journal-title":"Front Oncol."},{"key":"6137_CR26","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1007\/s00259-020-05095-0","volume":"48","author":"W Guo","year":"2021","unstructured":"Guo W, Pang Y, Yao L, Zhao L, Fan C, Ke J, et al. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [(68)Ga]Ga-FAPI-04 PET\/CT versus MRI and [(18)F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2021;48:1604\u201317. https:\/\/doi.org\/10.1007\/s00259-020-05095-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6137_CR27","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1182\/blood.2019003977","volume":"137","author":"DL Tao","year":"2021","unstructured":"Tao DL, Tassi Yunga S, Williams CD, McCarty OJT. Aspirin and antiplatelet treatments in cancer. Blood. 2021;137:3201\u201311. https:\/\/doi.org\/10.1182\/blood.2019003977.","journal-title":"Blood"},{"key":"6137_CR28","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","volume":"33","author":"M Haemmerle","year":"2018","unstructured":"Haemmerle M, Stone RL, Menter DG, Afshar-Kharghan V, Sood AK. The platelet lifeline to cancer: challenges and opportunities. Cancer Cell. 2018;33:965\u201383. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.002.","journal-title":"Cancer Cell"},{"key":"6137_CR29","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/hep.30289","volume":"69","author":"AE Sirica","year":"2019","unstructured":"Sirica AE, Gores GJ, Groopman JD, Selaru FM, Strazzabosco M, Wei Wang X, et al. Intrahepatic cholangiocarcinoma: continuing challenges and translational advances. Hepatology. 2019;69:1803\u201315. https:\/\/doi.org\/10.1002\/hep.30289.","journal-title":"Hepatology"},{"key":"6137_CR30","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/hep.26384","volume":"58","author":"M Cadamuro","year":"2013","unstructured":"Cadamuro M, Nardo G, Indraccolo S, Dall\u2019olmo L, Sambado L, Moserle L, et al. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. Hepatology. 2013;58:1042\u201353. https:\/\/doi.org\/10.1002\/hep.26384.","journal-title":"Hepatology"}],"updated-by":[{"DOI":"10.1007\/s00259-023-06188-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000}}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06137-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06137-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06137-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:03:38Z","timestamp":1684541018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06137-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["6137"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06137-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2290818\/v1","asserted-by":"object"}]},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"21 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00259-023-06188-2","URL":"https:\/\/doi.org\/10.1007\/s00259-023-06188-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in all figures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}